Tolerogenic dendritic cell-based treatment for multiple sclerosis (MS): a harmonised study protocol for two phase I clinical trials comparing intradermal and intranodal cell admini...

por Willekens, Barbara, Presas-Rodríguez, Silvia, Mansilla, MJ, Derdelinckx, Judith, Lee, Wai-Ping, Nijs, Griet, De Laere, Maxime, Wens, Inez, Cras, Patrick, Parizel, Paul, Van Hecke, Wim, Ribbens, Annemie, Billiet, Thibo, Adams, Geert, Couttenye, Marie-Madeleine, Navarro-Barriuso, Juan, Teniente-Serra, Aina, Quirant-Sánchez, Bibiana, Lopez-Diaz de Cerio, Ascensión, Inogés, Susana, Prosper, Felipe, Kip, Anke, Verheij, Herman, Gross, Catharina C, Wiendl, Heinz, Van Ham, Marieke (SM), Ten Brinke, Anja, Barriocanal, Ana Maria, Massuet-Vilamajó, Anna, Hens, Niel, Berneman, Zwi, Martínez-Cáceres, Eva, Cools, Nathalie, Ramo-Tello, Cristina
Publicado no BMJ Open (2019)